Skip to content
Home - Media - Press releases    
28 February 2006
AstraZeneca Issues 2005 Annual Report

AstraZeneca today published its 2005 Annual Report and Form 20-F Information, its 2005 Annual Review and its 2005 Corporate Responsibility Summary Report. These documents are available on the company’s website, www.astrazeneca.com/annualreport
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $23.95 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

Further enquiries to:

Media Enquiries:
Edel McCaffrey, Tel: +44 (0) 207 304 5034
Steve Brown, Tel: +44 (0) 207 304 5033

Investor Relations:
Mina Blair, Tel: +44 (0) 207 304 5084
Jonathan Hunt, Tel: +44 (0) 207 304 5087
AstraZeneca websites
Search